睾丸肿瘤抗原MAGEA1及MAGEA3在小鼠头颈部鳞癌及癌旁组织中的表达(3)
 |
| 第1页 |
参见附件(2089KB，3页)。
[参考文献]
[1]Scanlan MJ, Gure AO, Junghluth AA, et al. Cancer testis antigens: an expanding family of targets for cancer immunotherapy [J]. Immurnol Rev,2002,188:22-32.
[2]Inoue H, Mori M, Li J, et al. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes [J]. Int J caneer,1995,63(4):523-526.
[3]Takahashi K, Shiehijo S, Noguehi M, et al. Identification of MAGE-1 and -4 proteins in spermatogonia and primary spermatocytes of testis [J]. Cancer Res,1995,55:3478-3482.
[4]Itoh K, Hayashi A, Nakao M, et al. Human tumor rejection antigens MAGE [J]. J Biochem,1996,119(3):385-390.
[5]Eura M, Chikamatsu K, Ogi K, et al. Expression of genes MAGE-1, -2 and -3 by human maxillary carcinoma cells [J]. Anticancer Res,1995,15:55-60.
[6]Eura M, Ogi K, Chikamatsu K, et al. Expression of the MAGE gene family in human head and neek squamours-cell carcinomas [J]. Int J Cancer,1995,64(5):304-308.
[7]田俊.MAGEA1、MAGEA3、NY-ESO-1蛋白在喉鳞癌中的表达及意义[D].山西医科大学,2008.
[8]孙广滨,唐海红.喉癌组织及手术切缘P53、PCNA蛋白表达与局部复发的关系[J].第二军医大学学报,2008,29(4):413-417.
[9]邱蔚六.口腔癌诊治的现状和趋向[J].中华口腔医学杂志,2002,37(2):81-83.
[10]宋西成,潘新良,栾信庸,等.喉癌手术切缘的临床判别[J].山东大学基础医学院学报,2004,18(2):301-305.
(收稿日期：2009-03-24)
您现在查看是摘要介绍页，详见PDF附件(2089KB，3页)。